Diana Shipping Issues Final Proxy Reminder Ahead of Genco Annual Meeting, Urges Vote Against Board
GNK sits 84% above its 52-week low of $12.835 on light trading volume (0.3× avg).
Summary
Diana Shipping, a hostile bidder, issued a final proxy reminder urging Genco shareholders to vote for its director nominees and against Genco's defensive measures at the upcoming Annual Meeting, while its $24.80/share tender offer remains open.
Key Events · Ownership and Investor Activity · GNK
-
Final Proxy Solicitation
Diana Shipping issued a final reminder to Genco shareholders to vote for its two independent director nominees, Jens Ismar and Paul Cornell, at the Annual Meeting on June 18, 2026.
-
Opposition to Genco Proposals
Diana urges shareholders to vote "AGAINST" Genco's proposal to ratify its poison pill and its equity incentive plan, citing concerns about entrenchment and management's interests.
-
Hostile Tender Offer Remains Live
Diana's all-cash tender offer to acquire Genco for $24.80 per share remains open, expiring on June 26, 2026.
-
Governance Concerns Highlighted
Diana raised serious questions about Genco's governance changes, including the adoption of a poison pill and an "Employee Retention Plan" (severance arrangement) designed to protect current Chairman John Wobensmith and other senior executives.
Analysis · GNK · Energy & Transportation
Diana Shipping, a 14.4% shareholder, is making a final appeal to Genco shareholders two days before the Annual Meeting. Diana is pushing for the election of its two independent director nominees and urging votes against Genco's poison pill and an executive retention plan, which it claims are entrenchment mechanisms. This filing is a critical escalation in the ongoing hostile takeover attempt and proxy contest, with a $24.80 per share all-cash tender offer still active. The outcome of the shareholder vote will significantly impact Genco's governance and potential acquisition.
At the time of this filing, GNK was trading at $23.63 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $1B. The 52-week trading range was $12.84 to $27.25. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.